fbpx

Affinity Clinical Research

Latest News and Information

First Patient Enrolled in HCC trial

Immunotherapy is a growing therapeutic area for the treatment of cancer both in Australia and other countries and refers to any treatment that uses the patient’s natural defence system (immune system) to fight cancer2.  Several Checkpoint Inhibitors have been approved for use in Australia in the last few years, including pembrolizumab, nivolumab and ipilimumab.
read more

Staffing Clinical Trials

Investigator-Initiated research is exciting research.  It is attempting to answer questions asked by those at the coal face.  Who better than clinicians to know what problems face our patient day-to-day? I have been involved with Investigator-Initiated research for...

read more

First Patient Enrolled in HCC trial

Immunotherapy is a growing therapeutic area for the treatment of cancer both in Australia and other countries and refers to any treatment that uses the patient’s natural defence system (immune system) to fight cancer2.  Several Checkpoint Inhibitors have been approved for use in Australia in the last few years, including pembrolizumab, nivolumab and ipilimumab.
read more

Staffing Clinical Trials

Investigator-Initiated research is exciting research.  It is attempting to answer questions asked by those at the coal face.  Who better than clinicians to know what problems face our patient day-to-day? I have been involved with Investigator-Initiated research for...

read more